GHET1 and neoplasm: According to meta‐analysis results of Table 3, we found that the high expression of lncRNA GHET1 was associated with more advanced clinical stage (OR = 3.23, 95% CI: 2.25‐4.64), earlier lymph node metastasis (OR = 3.19, 95% CI: 1.85‐5.48), earlier distant metastasis (OR = 4.65, 95% CI: 1.99‐10.83) and bigger tumour size (OR = 2.95, 95% CI: 1.78‐4.89) (Figure 4).